← Back to All Filings

Nuvalent CLO Sells $2.25M in Stock via 10b5-1 Plan

Low SignificanceOctober 31, 2025 at 4:32:32 PM EDT

Nuvalent, Inc.

$NUVL4CIK: 0001861560

Subscribe to track NUVL

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Nuvalent CLO Sells $2.25M in Stock via 10b5-1 Plan

Company: Nuvalent, Inc. (NUVL) Form: 4 | Filed: 2025-10-31 Significance: Low

Insider: Miller Deborah Ann Title: Chief Legal Officer | Relationship: Officer

Transaction: • Type: Sell (following option exercise) • Shares: 21,800 • Price: ~$103.16 (avg) • Value: $2,248,946 • Owned After: 49,086

Key Insight: The insider exercised options and immediately sold the same number of shares. This is a typical "sell-to-cover" transaction with no change in the insider's net holdings, executed under a pre-arranged plan.

Market Context: The transaction represents just 0.031% of Nuvalent's $7.3B market cap, making it immaterial. The pre-scheduled nature (10b5-1 plan) further reduces its significance as a market signal.

Comprehensive Analysis

SEC Filing Analysis: Nuvalent, Inc. (NUVL)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Chief Legal Officer executed a pre-planned, cashless option exercise, selling approximately $2.25 million worth of stock to cover the exercise cost and taxes, with no change to her net share ownership.
  • Market Impact: Neutral. This transaction is considered routine executive compensation realization and is not indicative of a change in the insider's outlook on the company.

Company Information

FieldValue
CompanyNuvalent, Inc.
Ticker SymbolNUVL
CIK0001861560
IndustryPharmaceutical Preparations

Insider Information

FieldValue
NameMiller Deborah Ann
CIK0001868741
Title/PositionChief Legal Officer
RelationshipOfficer

Transaction Details

This filing reports an option exercise followed by a series of same-day sales to cover the cost. The net result is a disposition of shares on the open market.

FieldValue
Form Type4
Transaction Date2025-10-30
Transaction CodeM, S (Exercise and Sell)
Security TypeClass A Common Stock
Shares Involved21,800 (Sold)
Price Per Share$103.16 (Weighted Average Sale Price)
Total Value$2,248,946 (Total Sale Proceeds)
Shares Owned After49,086
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value (Sale)$2,248,946
% of Market Cap0.031%
Shares Transacted (Sale)21,800
% of Shares Outstanding0.033%
Post-Transaction Ownership49,086 shares (0.074% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The $2.25M sale is negligible against Nuvalent's $7.3 billion market capitalization. Such a small transaction does not move the needle on institutional or retail sentiment.
  • Ownership Concentration: The insider's post-transaction ownership of 0.074% is not a significant stake. The fact that her net share count remained unchanged (exercised 21,800 options, sold 21,800 shares) reinforces the interpretation that this was a liquidity event, not a divestment.
  • Dilution Impact: The transaction originates from an option exercise, which does introduce 21,800 new shares. However, this represents a minuscule 0.033% of shares outstanding, resulting in a negligible dilutive effect.
  • Transaction Significance: Based on the transaction's value being less than 0.1% of market cap and shares transacted being less than 0.1% of shares outstanding, the trade is quantitatively insignificant.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The market typically discounts sales conducted under 10b5-1 plans, especially when they are clearly for liquidity purposes (sell-to-cover). The small size of the transaction relative to the company's market cap and daily trading volume will likely result in no discernible price impact.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The shares sold are a small fraction of typical daily trading volume for a multi-billion dollar company.
  • Sentiment Indicator: Neutral. This is a routine executive compensation event, not a bearish signal.

Investment Insights

Positive Market Indicators

  • The transaction demonstrates that the executive's stock options are "in-the-money," reflecting past stock performance.

Risk Factors

  • No new risk factors are indicated by this filing. It is a standard, pre-planned transaction.

Key Takeaways

  1. Pre-Planned Sale: The transaction was executed under a Rule 10b5-1 trading plan, indicating it was scheduled in advance and not based on recent non-public information.
  2. Cashless Exercise: The insider exercised 21,800 options and sold the exact same number of shares, a common strategy to fund the option cost and associated taxes without a cash outlay.
  3. Immaterial Size: The sale's value is insignificant relative to Nuvalent's market capitalization, making it a non-event for the broader market.

Additional Context

Transaction Notes

  • Special Circumstances: Footnote 1 explicitly states, "These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024."
Topics:#NUVL#Nuvalent#InsiderTrading#SECFiling#Form4#InsiderSell#10b51#StockMarket#Biotech#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.